Purchases and Sales Made in Q3 2022 in Adverum Biotechnologies, Inc. (ADVM)
This table provides information about the institutional ownership of Adverum Biotechnologies, Inc. (ADVM) during Q3 2022. The information is specifically focused on institutions that hold shares of Adverum Biotechnologies, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-156K- 3.76% |
$150K - $1.51M
|
4M
$27.4M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-175K- 16.86% |
$168K - $1.69M
|
863K
$5.92M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-200K- 2.71% |
$192K - $1.94M
|
7.17M
$49.2M
|
|
|
Oct 31, 2022
Q3 2022
|
Monaco Asset Management Sam
|
SELL
|
- |
-222K- 49.66% |
$213K - $2.15M
|
225K
$1.54M
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-417K- 25.57% |
$400K - $4.04M
|
1.21M
$8.33M
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-453K- 30.09% |
$435K - $4.38M
|
1.05M
$7.22M
|